ESTERO, FLORIDA / ACCESS Newswire / September 3, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), developer of a multi-faceted patent-pending drug delivery technology, ...
(RTTNews) - Galmed Pharmaceuticals (GLMD) announced positive preliminary results from Part 1 of the Ph1 Bioavailability AM-001 Study of Aramchol Meglumine. The company said initial findings suggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback